Although the vast majority of genetic alterations were detected using the GEL variant calling pipelines, copy number alterations were not detected in MDM2 and TBXT, nor were SSX2 fusion genes in synovial sarcoma identified. The gene discussed is MDM2; the disease is synovial sarcoma.